Viewing Study NCT03371251

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:40 PM
Ignite Modification Date: 2026-02-28 @ 11:18 AM
Study NCT ID: NCT03371251
Status: COMPLETED
Last Update Posted: 2022-03-14
First Post: 2017-12-08
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care
Sponsor: Boston Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Systemic Lupus Erythematosus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Adults View
None BOS161721 View
None standard of care View
None moderately to severely active Systemic Lupus Erythematosus View